Orladeyo 150 mg, Hartkapseln

7680684640018 CH-68464 Hartkapseln

Associated product:

ORLADEYO caps 150 mg 28 pce
Orladeyo 150 mg, Hartkapseln
Orladeyo 150 mg, Hartkapseln
Orladeyo 150 mg, Hartkapseln
1 / 3
google

Article details

Package size
28
Selling units
unbekannt
Measure
Hartkapseln
Galenic form
Hartkapseln
Galenic group
Unknown

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
04/06/2025
Summary of Product Characteristics
Français
04/06/2025
Summary of Product Characteristics
Italien
04/06/2025
Patient information leaflet
Allemand
12/03/2025
Patient information leaflet
Français
12/03/2025
Patient information leaflet
Italien
12/03/2025

Detailed composition

Substance Quantity Type Category
(N/A)
150.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance FIMDK
(N/A)
- Substance FTODK
(N/A)
- Substance FTODK
(N/A)
- Substance HNIDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance HNIDK
(N/A)
- Substance FTODK

Reimbursement information

Public price
CHF 13396.10
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/07/2022

Authorization holder

BioCryst Schweiz GmbH

6300 ZUG

Authorization information

Swissmedic authorization number
68464
Drug name
Orladeyo, Hartkapseln
Galenic form
KAHA
ATC Code
B06AC06
Authorization status
Z
Dispensing category
B
First authorization
07/06/2022
Authorization expiration date
06/06/2027
IT Number
02.99.0.
Domain
Human medicine
Field of application
Hereditäres Angioödem

Package details

Description (FR)
ORLADEYO caps 150 mg 28 pce
Description (DE)
ORLADEYO Kaps 150 mg 28 Stk
Market launch
07/06/2022
Narcotic (BTM)
No